Cargando…

1095. Investigation of Risk Factors Associated with Serious Bacterial, Viral and Invasive Fungal Infections in Hematologic Patients on Ibrutinib

BACKGROUND: Ibrutinib is a tyrosine kinase inhibitor used to treat hematologic malignancies that may increase the risk of serious infection including invasive fungal infections (IFI). In a study of 378 patients with hematologic malignancy on ibrutinib, serious infection and IFI occurred in 11% and 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Holowka, Thomas, Cheung, Harry, Malinis, Maricar F, Perreault, Sarah, Isufi, Iris, Azar, Marwan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776795/
http://dx.doi.org/10.1093/ofid/ofaa439.1281

Ejemplares similares